-
Mashup Score: 92In APL, 2 targets are better than 1! - 2 month(s) ago
In this issue of Blood, Voso et al1 present an analysis of long-term outcomes for 1438 patients with acute promyelocytic leukemia (APL). Their data, accumu
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 92In APL, 2 targets are better than 1! - 2 month(s) ago
In this issue of Blood, Voso et al1 present an analysis of long-term outcomes for 1438 patients with acute promyelocytic leukemia (APL). Their data, accumu
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
In APL, 2 targets are better than 1! https://t.co/KAVXStfkyo #myeloidneoplasia https://t.co/mfGD6nZ1Jo
-
-
Mashup Score: 44Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML - 2 month(s) ago
Abstract. The European LeukemiaNet 2024 risk-stratification guidelines for patients with acute myeloid leukemia receiving hypomethylating agents combined w
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML https://t.co/xnQwR8Iux7 #myeloidneoplasia
-
-
Mashup Score: 30Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin - 3 month(s) ago
Key PointsFLT3-ITD MRD identifies patients at high relapse risk after intensive chemotherapy with midostaurin.Conversion from FLT3-ITD MRDneg to FLT3-ITD M
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Conversion from FLT3-ITD MRDneg to FLT3-ITD MRDpos during follow-up was associated with a high relapse rate and inferior outcome. https://t.co/3ES4G8Qk8C #myeloidneoplasia https://t.co/31sYhzgVmi
-
-
Mashup Score: 60Risk of bleeding in patients with essential thrombocythemia and extreme thrombocytosis - 3 month(s) ago
Key PointsNo difference in the cumulative incidence of bleeding in ET patients with vs without ExT.There is no clear indication for cytoreduction to decrea
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
There is no clear indication for cytoreduction to decrease bleeding risk based on a platelet threshold of 1 million alone. https://t.co/RxH14XIYdc #myeloidneoplasia # https://t.co/fCoJN9XcJS
-
-
Mashup Score: 35Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia - 3 month(s) ago
Abstract. Pretransplant detection of KMT2Ar measurable residual disease ≥0.001% by quantitative polymerase chain reaction was associated with significantly
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia https://t.co/q4jhsvJhoE #myeloidneoplasia
-
-
Mashup Score: 1Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms - 3 month(s) ago
Key PointsIDCH differs from LCH in its clinical, molecular, and immunohistochemical features.IDCH is often associated with other hematopoietic neoplasms, a
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
IDCH is often associated with other hematopoietic neoplasms, and such cases are associated with an inferior prognosis. https://t.co/L0DlbRYKo8 #myeloidneoplasia https://t.co/A9cYlWaabb
-
-
Mashup Score: 6Diabetes mellitus, metformin, and the risk of MPN - 3 month(s) ago
TO THE EDITOR:
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
Diabetes mellitus, metformin, and the risk of MPN https://t.co/Qv51wMWVWm #myeloidneoplasia
-
-
Mashup Score: 21INCA033989: the first shot on goal for MPNs? - 3 month(s) ago
Abstract. In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myelopr
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
INCA033989: the first shot on goal for MPNs? https://t.co/yDbHKUYize #myeloidneoplasia https://t.co/Vesh6paR12
-
-
Mashup Score: 21INCA033989: the first shot on goal for MPNs? - 3 month(s) ago
Abstract. In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myelopr
Source: ashpublications.orgCategories: General Medicine News, Oncologists1Tweet-
INCA033989: the first shot on goal for MPNs? https://t.co/yDbHKUYize #myeloidneoplasia https://t.co/Vesh6paR12
-
In APL, 2 targets are better than 1! https://t.co/KAVXStfkyo #myeloidneoplasia https://t.co/mfGD6nZ1Jo